National Cancer Center, Korea

This study tests whether adding surgery and heated chemotherapy (HIPEC) to standard care helps women with platinum-resistant ovarian cancer live longer without the disease getting worse. About 140 participants will be randomly assigned to receive either surgery plus HIPEC or stan…

This study tests a drug called lurbinectedin in 46 people with high-grade pancreatic neuroendocrine tumors that have not responded to standard treatment. The goal is to see if the drug can shrink or control the tumors. Participants must have a confirmed diagnosis and meet blood c…

This study is for people with triple-negative breast cancer who still have cancer after initial chemotherapy and surgery. It compares the usual follow-up drug (capecitabine) alone versus adding an immunotherapy drug (atezolizumab) to see if the combination helps prevent the cance…

This study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with advanced adrenal cortical carcinoma that has not responded to standard chemotherapy. The goal is to see if this treatment can shrink or control the cancer. About 30 adults will take part, re…

This study is creating a detailed registry of pancreatic cancer patients in Korea, combining past records from 2010 to 2022 with new data collected through 2029. Over 6,900 participants will contribute information to help researchers understand the disease better and develop real…